期刊文献+

强直性脊柱炎伴发葡萄膜炎82例临床分析 被引量:3

Clinical analysis of 82 cases of ankylosing spondylitis associated with uveitis
下载PDF
导出
摘要 目的探讨强直性脊柱炎(AS)伴发葡萄膜炎的临床特点及药物治疗疗效。方法回顾性分析82例AS伴葡萄膜炎患者的临床资料。结果 82例AS伴葡萄膜炎患者平均年龄(34.99±8.28)岁,其中男性占85.37%,HLA-B27阳性率为87.80%,葡萄膜炎评分(5.56±2.04)分。经非甾体类抗炎药、改善病情药物及眼科局部用药后,患者葡萄膜炎症状缓解,视力提高,眼部炎症消失,腰痛改善,血沉、C反应蛋白(CRP)、强直性脊柱炎疾病活动性指数(BASDAI)和强直性脊柱炎功能指数(BASFI)与治疗前比较差异均有统计学意义(P<0.05)。结论 AS伴发葡萄膜炎多见于青壮年男性,单侧受累为主,大部分患者HLA-B27阳性,及时有效治疗疗效确切,一般预后良好。 Objective To investigate the clinical characteristics and therapeutic effect ofankylosing spondy- litis (As) associated with uveitis. Methods The clinical data of 82 patients of AS associated with uveitis were ana- lyzed to review the clinical characteristics and therapeutic effect. Results The mean age of the patients was (34.994±8.28) years and 85.37% of the patients were male. HLA-B27 positivity was 87.80%. Scoring for uveitis was (5.564± 2.04). After treating with non-steroids anti-inflammatory drugs, disease modifying drugs and local ophthalmologic treatment, the symptoms of uveitis got relieved, acuity of vision was improved and the inflammation of the eyes dis- appeared, and the back pain was relieved. Erythroeyte sedimentation rate, C-reactive protein (CRP), Bath Ankylos- ing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) de- creased (P〈0.05). Conduslon AS associated with uveitis often affects young male, with mostly unilateral involved, and most of the patients are HLA-B27 positive. Prompt and potent treatment lead to satisfactory therapeutic effect and usually favorable prognosis.
出处 《海南医学》 CAS 2014年第20期3059-3061,共3页 Hainan Medical Journal
基金 国家自然基金项目青年科学基金项目(编号:81301529) 广东省自然科学基金博士启动项目(编号:S2013040012296) 深圳市福田区卫生公益性科研项目(编号:FTWS201308)
关键词 强直性脊柱炎 葡萄膜炎 HLA-B27 Ankylosing spondylitis Uveitis I-ILA-B27
  • 相关文献

参考文献12

二级参考文献25

  • 1Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath Ankylosing Spondylitis Functional Index [J]. J Rheumatol, 1994,21 ( 21 ) : 2281-2285.
  • 2Boonen A. A review of work-participation, cost-of-illness and costeffectiveness studies in ankylosing spondylitis [J]. Nat Clin Pract Rheumatol, 2006,2 ( 10 ) : 546 -553.
  • 3Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA-B~ homozygosity in ankylosing spondylitis [ J ]. Ann Rheum Dis, 2006,65 (6) : 775-780.
  • 4Levy-Clarke G, Grace T, Nussenblatt L, et al. Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis [J]? Nat Clin Pract Rheumatol,2006,2(2):72-73.
  • 5Van der linden S, VHA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria [ J ]. Arthritis Rheum, 1984,27 (4) : 361-368.
  • 6Garrett S, Jenkinson T, Kennedy L G, et al. A new approach to defining disease status in ankylosing spondylitis:the Bath Ankylosing Spondylitis Disease Activity Index [J ]. J Rheumatol, 1994,21 (12): 2286-2291.
  • 7Nussenblatt RB. The natural history of uveitis. Int Ophthalmol, 1990, 14: 303-308.
  • 8Romday MJH, Stilma JS, Barbe RF, et al. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol, 1994, 78: 690- 693.
  • 9Suttop-Schulten MSA, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol, 1996, 80: 844-848.
  • 10周文炳 彭寿雄.青光眼盲目原因的分析[J].中华眼科杂志,1985,21:28-31.

共引文献36

同被引文献19

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部